Ouaguia L, Morales O, Mrizak D, Sénéchal M, Ghazal K, Boleslawski E, de Launoit Y, Conti F* and Delhem N* (* Equally contributed authors). Case Report: Overexpression of Regulatory T-Cells Type 1 (Tr1) specific markers in a patient with HCV-induced Hepatocellular Carcinoma. ISRN Hepatology. 2013; In press.

Stenard F*, Morales O*, Ghazal K, Viallon V, Aoudjehane L, Ouaguia L, Calmus Y, Conti F* and Delhem N* (* Equally contributed authors). CD49b, a major marker of regulatory T-cells type 1, predict the response to antiviral therapy of recurrent hepatitis C after liver transplantation. BRMI, 2013; In press.

Rafa H, Saoula H, Belkhelfa M, Medjeber O, Soufli I, Toumi R, de Launoit Y, Moralès O, Nakmouche M, Touil-Boukoffa C*, Delhem N* (* Equally contributed authors). IL-23/IL-17A Axis Correlates with the Nitric Oxide Pathway in Inflammatory Bowel Disease: Immunomodulatory Effect of Retinoic acid. J Interferon Cytokine Res. 2013; 33(7) : 355-368.

Boleslawski E, Bouras AF, Truant S, Liddo G, Herrero A, Badic B, Audet M, Altieri M, Laurent A, Declerck N, Navarro F, Létoublon C, Wolf P, Chiche L, Cherqui D, Pruvot FR. Hepatic artery ligation for arterial rupture following liver transplantation: a reasonable option. Am J Transplant. 2013; 13(4) : 1055-1062.


Ndour PA, Brocqueville G, Ouk TS, Goormachtigh G, Morales O, Mougel A, Bertout J, Melnyk O, Fafeur V, Feuillard J, Coll J, Adriaenssens E. Inhibition of the latent membrane protein-1 impairs the growth and tumorigeneses of an EBV-latency II transformed T cell. J Virol. 2012; 86(7) : 3934-3943.

Delhem N, Morales O. Regulatory T cells and Liver Transplantation for Hepatitis C Cirrhosis.  Le Courrier de la Transplantation – Vol. XII – n° 1 – janvier-février-mars 2012.

Moralès O, Richard A, Martin N, Mrizak D, Sénéchal M, Miroux C, Pancré V, Rommelaere J, Caillet-Fauquet P, de Launoit Y, Delhem N. Activation of a helper and not regulatory human CD4+ T cell response by oncolytic H-1 parvovirus. PLoS One. 2012; 7(2): e32197.

Moralès O, Depil S, Mrizak D, Martin N, Ndour PA, Dufosse F, Miroux C, Coll J, de Launoit Y, Auriault C, Pancre V, Delhem N. EBV Latency II-derived peptides induce a specific CD4+ cytotoxic t-cell activity and not a CD4+ regulatory T-cell response. J Immunother. 2012; 35(3): 254-266.

Miroux C, Morales O, Ouaguia L, Aoudjehane L, Boleslawski E, Pancré V, de Launoit Y, Calmus Y, Conti F*, Delhem N* (* Equally contributed authors). Corticosteroids do not reverse the inhibitory effect of cyclosporine on regulatory T-cell activity in contrast to mycophenolate mofetil. Transplant Proc. 2012; 44(9) : 2834-2839.

Miroux C, Morales O, Ghazal K, Othman SB, de Launoit Y, Pancré V, Conti F*, Delhem N* (* Equally contributed authors). In Vitro Effects of Cyclosporine A and Tacrolimus on Regulatory T-Cell Proliferation and Function. Transplantation. 2012; 94(2) : 123-131.

Chenivesse C, Chang Y, Azzaoui I, Ait Yahia S, Morales O, Plé C, Foussat A, Tonnel AB, Delhem N, Yssel H, Vorng H, Wallaert B, Tsicopoulos A. Pulmonary CCL18 Recruits Human Regulatory T Cells. J Immunol. 2012; 189(1) : 128-137.


Boleslawski E, Othman SB, Aoudjehane L, Chouzenoux S, Scatton O, Soubrane O, Calmus Y, Conti F*, Delhem N* (* Equally contributed authors). CD28 expression by peripheral blood lymphocytes as a potential predictor of the development of de novo malignancies in long-term survivors after liver transplantation. Liver Transpl. 2011; 17(3) : 299-305.

Azzaoui I, Ait Yahia S, Chang Y, Vorng H, Morales O, Fan Y, Delhem N, Ple C, Tonnel AB, Wallaert B, Tsicopoulos A.CCL18 differentiates dendritic cells in tolerogenic cells able to prime regulatory T cells in healthy subjects. Blood. 2011; 118 : 3549-3558.


Miroux C, Vausselin T, Delhem N. Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response. Expert Opin Biol Ther. 2010; 10(11) : 1563-1572.

Delhem N, Miroux C, Vausselin T. Regulatory T Cells and Hepatocellular Carcinoma: Implication of the Regulatory T Lymphocytes in the Control of the Immune Response. In: Regulatory T Cells. Editor: Ren S. Hayashi. 2010; Chap 7: pp 1-15.

Chang Y, de Nadai P, Azzaoui I, Morales O, Delhem N, Vorng H, Tomavo S, Ait Yahia S, Zhang G, Wallaert B, Chenivesse C, Tsicopoulos A. The chemokine CCL18 generates adaptive regulatory T cells from memory CD4+ T cells of healthy but not allergic subjects. FASEB J. 2010; 24(12) : 5063-5072.


Carpentier A, Conti F, Carrière M, Aoudjehane L, Miroux C, Moralès O, Calmus Y, Groux H, Auriault C, Pancré V, Podevin P*, Delhem N* (* Equally contributed authors). Analysis of gene transcription in sera during chronic hepatitis C infection. J Med Virol. 2009; 81(3) : 473-480.

Miroux C, Moralès O, Carpentier A, Dharancy S, Conti F, Boleslowski E, Podevin P, Auriault C, Pancré V, Delhem N. Inhibitory effects of cyclosporine on human regulatory T cells in vitro. Transplant Proc. 2009; 41(8) : 3371-3374.

Carpentier A, Conti F, Stenard F, Aoudjehane L, Miroux C, Podevin P, Morales O, Chouzenoux S, Scatton O, Groux H, Auriault C, Calmus Y, Pancre V, Delhem N. Increased expression of regulatory Tr1 cells in recurrent hepatitis C after liver transplantation. Am J Transplant. 2009; 9(9) : 2102-2112.


Delhem N, Carpentier A, Moralès O, Miroux C, Groux H, Auriault C, Pancré V. [Regulatory T-cells and hepatocellular carcinoma: implication of the regulatory T lymphocytes in the control of the immune response]. Bull Cancer. 2008; 95(12) : 1219-1225.

Delhem N, Cottrez F, Carpentier A, Miroux C, Moralès O, François V, Groux H, Auriault C, Pancré V. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression]. Bull Cancer. 2008; 95(11) : 1029-1038.